K2M acquired exclusive license to a portfolio of 17 issued and pending patents for expandable interbody fusion devices (IBFs), which will support development of new products using Lamellar 3D Titanium Technology™.
K2M expects the IP will yield devices with greater expansion capabilities than many available today.
The company is already well-established in 3D printing of devices for complex, MIS and degenerative spine procedures. Recent FDA 510(k) clearances from 2Q17 include MOJAVE™ posterior lumbar expandable IBF and the CAPRI™ Small 3D Static Corpectomy Cage for thoracolumbar stabilization.
Other spine companies that employ 3D or additive techniques include:
- 4WEB Medical, the Curved Posterior Spine Truss, Lateral Spine Truss IBF, etc.
- EIT/Emerging Implant Technologies' EIT Cellular Titanium, used in recently-cleared IBFs
- Nexus Spine, the Tranquil IBF system
- Nexxt Spine's NanoMatrixx 3D-printed porous bioactive titanium material for IBF
- Renovis Surgical, Tesera SC porous titanium cervical IBF
- Spineart's JULIET Ti lumbar IBF systems
- Stryker Spine, the Tritanium PL Interbody Cage
Sources: K2M, Inc.; ORTHOWORLD Inc.